Literature DB >> 29628442

Obstructive sleep apnea and effects of continuous positive airway pressure on triglyceride-rich lipoprotein metabolism.

Luciano F Drager1, Thauany M Tavoni2, Vanessa M Silva2, Raul D Santos3, Rodrigo P Pedrosa4, Luiz A Bortolotto1, Carmen G Vinagre2, Vsevolod Y Polotsky5, Geraldo Lorenzi-Filho6, Raul C Maranhao7.   

Abstract

This study aimed to explore lipoprotein metabolism in obstructive sleep apnea (OSA) and the effects of continuous positive airway pressure (CPAP). We studied 15 men with severe OSA [apnea-hypopnea index (AHI) ≥30 events/hour] and 12 age-, BMI-, and waist circumference-matched volunteers without OSA (AHI <5 events/hour). Carotid intima-media thickness (CIMT) was determined by a blind examiner. After 12 h fasting, a triglyceride-rich chylomicron-like emulsion, labeled with [14C]cholesteryl oleate and [3H]triolein, was injected intravenously followed by blood sample collection at preestablished times. Fractional clearance rate (FCR) of the radiolabeled lipids was estimated by compartmental analysis of radioisotope decay curves. Compared with controls, patients with OSA showed a significant delay in both cholesteryl ester FCR (0.0126 ± 0.0187 vs. 0.0015 ± 0.0025 min-1; P = 0.0313) and triglycerides FCR (0.0334 ± 0.0390 vs. 0.0051 ± 0.0074 min-1; P = 0.0001). CIMT was higher in the OSA group: 620 ± 17 vs. 725 ± 29 µm; P = 0.004. Cholesteryl ester FCRs were inversely related to total sleep time <90% (r = -0.463; P = 0.029) and CIMT (r = -0.601; P = 0.022). The triglyceride FCR was inversely correlated with AHI (r = -0.537; P = 0.04). In a subgroup of patients treated with CPAP for 3 months (n = 7), triglyceride FCR increased 5-fold (P = 0.025), but the cholesteryl ester FCR was unchanged. In conclusion, severe OSA decreased lipolysis of triglyceride-rich lipoproteins and delayed removal of remnants. CPAP treatment may be effective to restore the lipolysis rates.
Copyright © 2018 Drager et al.

Entities:  

Keywords:  cardiovascular diseases; chylomicron remnants; chylomicrons; clinical studies; lipid and lipoprotein metabolism; lipoprotein kinetics; postprandial lipidemia

Mesh:

Substances:

Year:  2018        PMID: 29628442      PMCID: PMC5983397          DOI: 10.1194/jlr.M083436

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Early signs of atherosclerosis in obstructive sleep apnea.

Authors:  Luciano F Drager; Luiz A Bortolotto; Maria Cecília Lorenzi; Adelaide C Figueiredo; Eduardo M Krieger; Geraldo Lorenzi-Filho
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

Review 3.  Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

Authors:  Børge G Nordestgaard
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  Association of sleep apnea and type II diabetes: a population-based study.

Authors:  Kevin J Reichmuth; Diane Austin; James B Skatrud; Terry Young
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

5.  Impact of OSA on cardiovascular events after coronary artery bypass surgery.

Authors:  Carlos Henrique G Uchôa; Naury de Jesus Danzi-Soares; Flávia S Nunes; Altay A L de Souza; Flávia B Nerbass; Rodrigo P Pedrosa; Luiz Antonio M César; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

6.  Delayed intravascular catabolism of chylomicron-like emulsions is an independent predictor of coronary artery disease.

Authors:  Andrei C Sposito; Laura I Ventura; Carmen G Vinagre; Pedro A Lemos; Edgard Quintella; Raul D Santos; Otavio Carneiro; Jose A F Ramires; Raul C Maranhão
Journal:  Atherosclerosis       Date:  2004-10       Impact factor: 5.162

Review 7.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

8.  Metabolism of protein-free lipid emulsion models of chylomicrons in rats.

Authors:  T G Redgrave; R C Maranhao
Journal:  Biochim Biophys Acta       Date:  1985-06-14

9.  Chylomicronemia elicits atherosclerosis in mice--brief report.

Authors:  Michael M Weinstein; Liya Yin; Yiping Tu; Xuping Wang; Xiaohui Wu; Lawrence W Castellani; Rosemary L Walzem; Aldons J Lusis; Loren G Fong; Anne P Beigneux; Stephen G Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-08       Impact factor: 8.311

10.  Decreased lipoprotein lipase in obstructive sleep apnea syndrome.

Authors:  Ken Iesato; Koichiro Tatsumi; Toshiji Saibara; Akira Nakamura; Jiro Terada; Yuji Tada; Seiichiro Sakao; Nobuhiro Tanabe; Yuichi Takiguchi; Takayuki Kuriyama
Journal:  Circ J       Date:  2007-08       Impact factor: 2.993

View more
  6 in total

1.  Obesity and Obstructive Sleep Apnea.

Authors:  Maria R Bonsignore
Journal:  Handb Exp Pharmacol       Date:  2022

2.  Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity.

Authors:  Viseslav Popadic; Milica Brajkovic; Slobodan Klasnja; Natasa Milic; Nina Rajovic; Danica Popovic Lisulov; Anica Divac; Tatjana Ivankovic; Andrea Manojlovic; Novica Nikolic; Lidija Memon; Marija Brankovic; Maja Popovic; Ana Sekulic; Jelica Bjekic Macut; Olivera Markovic; Sinisa Djurasevic; Maja Stojkovic; Zoran Todorovic; Marija Zdravkovic
Journal:  Front Pharmacol       Date:  2022-05-25       Impact factor: 5.988

3.  Obstructive sleep apnea is associated with lower adiponectin and higher cholesterol levels independently of traditional factors and other sleep disorders in middle-aged adults: the ELSA-Brasil cohort.

Authors:  Wagner A Silva; Bianca Almeida-Pititto; Ronaldo B Santos; Aline N Aielo; Soraya Giatti; Barbara K Parise; Silvana P Souza; Sandra F Vivolo; Paulo A Lotufo; Isabela M Bensenor; Luciano F Drager
Journal:  Sleep Breath       Date:  2021-02-15       Impact factor: 2.816

4.  TLR4 mediates inflammation and hepatic fibrosis induced by chronic intermittent hypoxia in rats.

Authors:  Zhi-Peng Lin; Hui-Li Lin; Xue-Ping Yu; Yi-Juan Zheng; Si-Yu Cheng
Journal:  Mol Med Rep       Date:  2020-05-07       Impact factor: 2.952

5.  The Association of Obstructive Sleep Apnea and Nocturnal Hypoxemia with Lipid Profiles in a Population-Based Study of Community-Dwelling Australian Men.

Authors:  Layla B Guscoth; Sarah L Appleton; Sean A Martin; Robert J Adams; Yohannes A Melaku; Gary A Wittert
Journal:  Nat Sci Sleep       Date:  2021-10-08

6.  The effect of acute intermittent hypoxia on postprandial triglyceride levels in humans: a randomized crossover trial.

Authors:  Renée Morin; Jean-François Mauger; Ruwan Amaratunga; Pascal Imbeault
Journal:  J Transl Med       Date:  2021-06-22       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.